View the most recent data and latest information on option chains for Phibro Animal Health Corporation Class A Common Stock (PAHC) at Nasdaq.com.
中文名: Phibro Animal Health Corporation Class A 公司名称: Phibro Animal Health Corp. 所属行业: 健康科技 / 主要药品 交易所: 纳斯达克交易所 股票分析 最近更新于 2025-04-04 7 超过76%的股票 行业排名 9/313 市场排名 1158/4922 机构预测 当前价 $19.190 目标均价 $20.75 最高目标价 $27.00...
One company to watch right now isPhibro Animal Health (PAHC). PAHC is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. The stock holds a P/E ratio of 12.16, while its industry has an average P/E of 21.98. Over the last 12 months, PAHC's Forward P/E has b...
新闻稿:Phibro Animal Health公司将举办关于第三季度业绩的网络直播和看涨会议 Phibro Animal Health公司将在2025年4月23日举行网络广播和电话会议,讨论第三季度业绩。新泽西州特恩克--(商业电讯)-- Phibro Animal Health公司(纳斯达克:PAHC)预计 道琼斯04/24 04:00 快讯| Phibro Animal Health CORP:美银全球货币研究...
financial health Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock: Check outHistorical Fundamental Analysis of Phibro Animalto cross-verify your projections. PharmaceuticalsPharmaceuticals, Biotechnology & Life SciencesHealth CareNASDAQ Biotechno...
公司名称Phibro Animal Health 上市日期2014/04/11 发行价格15.00 成立日期1946 CEOMr. Jack Clifford Bendheim 所属市场纳斯达克 员工数量1940 年结日06-30 公司地址Glenpointe Centre East,300 Frank W. Burr Boulevard,Suite 21, 3rd floor 城市Teaneck ...
Our Class A common stock trades on the Nasdaq Stock Market (“Nasdaq”) under the trading symbol “PAHC.” Our Class B common stock is not listed or traded on any stock exchange. We are a Delaware corporation. Phibro Animal Health Corporation reported net sales of $1 billion for the fis...
巴克莱:维持Phibro Animal Health(PAHC.US)评级,由减持调整至减持评级, 目标价由10.00美元调整至13.00美元。 Phibro Animal Health(PAHC.US)公司简介:Phibro Animal Health Corp是一家主要在美国经营的多元化动物健康和矿物营养公司。它通过三个部门经营:动物健康、矿物质营养和性能产品。该公司开发、生产和销售包括家禽...
Photo: Jonatan Rundblad/Adobe Stock Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million. The 2 parties announced the definitive agreement on Sunday, April 28, 2024, in a joint news release....
Phibro Animal Health(PAHC.US):2022年Q4财报实现营收2.553亿美元,前值为2.203亿美元,预期值为2.46亿美元,超出市场预期3.77%;每股收益为0.36美元,前值为0.32美元,预期值为0.38美元,比市场预期低5.26%。 Phibro Animal Health(PAHC.US)公司简介:菲布罗动物保健公司从事动物保健和矿物质营养产品的制造和供应。它通过以下...